Moxibustion improves experimental colitis in rats with Crohn's disease by regulating bile acid enterohepatic circulation and intestinal farnesoid X receptor

被引:4
作者
Shen, Jia-Cheng [1 ,2 ]
Qi, Qin [2 ]
Han, Dong [1 ,2 ]
Lu, Yuan [2 ]
Huang, Rong [2 ]
Zhu, Yi [2 ]
Zhang, Lin-Shan [1 ]
Qin, Xiu-Di [2 ]
Zhang, Fang [2 ]
Wu, Huan-Gan [2 ]
Liu, Hui-Rong [2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Key Lab Acupuncture & Immunol Effects, Shanghai 200030, Peoples R China
[2] Shanghai Res Inst Acupuncture & Meridian, Shanghai 200030, Peoples R China
来源
JOURNAL OF INTEGRATIVE MEDICINE-JIM | 2023年 / 21卷 / 02期
关键词
Crohn's disease; Moxibustion; Bile acid; Farnesoid X receptor; Colitis; Intestinal mucosal barrier; INFLAMMATORY-BOWEL-DISEASE; HERB-PARTITIONED MOXIBUSTION; HEPATOBILIARY MANIFESTATIONS; COMPLICATIONS; PREVALENCE; MECHANISMS; EXPRESSION; THERAPIES; PATHWAY; SYSTEM;
D O I
10.1016/j.joim.2023.01.001
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective: This study was conducted to explore the mechanism of intestinal inflammation and barrier repair in Crohn's disease (CD) regulated by moxibustion through bile acid (BA) enterohepatic circulation and intestinal farnesoid X receptor (FXR).Methods: Sprague-Dawley rats were randomly divided into control group, CD model group, mild moxi-bustion group and herb-partitioned moxibustion group. CD model rats induced by 2,4,6-trinitrobenzene sulfonic acid were treated with mild moxibustion or herb-partitioned moxibustion at Tianshu (ST25) and Qihai (CV6). The changes in CD symptoms were rated according to the disease activity index score, the serum and colon tissues of rats were collected, and the pathological changes in colon tis-sues were observed via histopathology. Western blot, immunohistochemistry (IHC) and immunofluores-cence were used to evaluate the improvement of moxibustion on intestinal inflammation and mucosal barrier in CD by the BA-FXR pathway.Results: Mild moxibustion and herb-partitioned moxibustion improved the symptoms of CD, inhibited inflammation and repaired mucosal damage to the colon in CD rats. Meanwhile, moxibustion could improve the abnormal expression of BA in the colon, liver and serum, downregulate the expression of interferon-c and upregulate the expression of FXR mRNA, and inhibit Toll-like receptor 4 (TLR4) and mye-loid differentiation factor 88 (MyD88) mRNA. The IHC results showed that moxibustion could upregulate the expression of FXR and mucin2 and inhibit TLR4 expression. Western blot showed that moxibustion inhibited the protein expression of TLR4 and MyD88 and upregulated the expression of FXR. Immunofluorescence image analysis showed that moxibustion increased the colocalization sites and intensity of FXR with TLR4 or nuclear factor-jB p65. In particular, herb-partitioned moxibustion has more advantages in improving BA and upregulating FXR and TLR4 in the colon.Conclusion: Mild moxibustion and herb-partitioned moxibustion can improve CD by regulating the enterohepatic circulation stability of BA, activating colonic FXR, regulating the TLR4/MyD88 pathway, inhibiting intestinal inflammation and repairing the intestinal mucosal barrier. Herb-partitioned moxi-bustion seems to have more advantages in regulating BA enterohepatic circulation and FXR activation. Please cite this article as: Shen JC, Qi Q, Han D, Lu Y, Huang R, Zhu Y, Zhang LS, Qin XD, Zhang F, Wu HG, Liu HR. Moxibustion improves experimental colitis in rats with Crohn's disease by regulating bile acid enterohepatic circulation and intestinal farnesoid X receptor. J Integr Med. 2023; 21(2): 194-204.(c) 2023 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine.
引用
收藏
页码:194 / 204
页数:11
相关论文
共 55 条
  • [1] Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
    Bonovas, Stefanos
    Fiorino, Gionata
    Allocca, Mariangela
    Lytras, Theodore
    Nikolopoulos, Georgios K.
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (10) : 1385 - +
  • [2] Identification of a choroid plexus vascular barrier closing during intestinal inflammation
    Carloni, Sara
    Bertocchi, Alice
    Mancinelli, Sara
    Bellini, Martina
    Erreni, Marco
    Borreca, Antonella
    Braga, Daniele
    Giugliano, Silvia
    Mozzarelli, Alessandro M.
    Manganaro, Daria
    Perez, Daniel Fernandez
    Colombo, Federico
    Di Sabatino, Antonio
    Pasini, Diego
    Penna, Giuseppe
    Matteoli, Michela
    Lodato, Simona
    Rescigno, Maria
    [J]. SCIENCE, 2021, 374 (6566) : 439 - +
  • [3] MIG in Crohn's disease
    Caruso, C.
    [J]. CLINICA TERAPEUTICA, 2019, 170 (03): : E206 - E210
  • [4] Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model
    Chen, Guangxin
    Ran, Xin
    Li, Bai
    Li, Yuhang
    He, Dewei
    Huang, Bingxu
    Fu, Shoupeng
    Liu, Juxiong
    Wang, Wei
    [J]. EBIOMEDICINE, 2018, 30 : 317 - 325
  • [5] Management of Crohn Disease A Review
    Cushing, Kelly
    Higgins, Peter D. R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (01): : 69 - 80
  • [6] New therapies for inflammatory bowel disease: from the bench to the bedside
    Danese, Silvio
    [J]. GUT, 2012, 61 (06) : 918 - 932
  • [7] Thematic Review Series: Intestinal Lipid Metabolism: New Developments and Current Insights Intestinal transport and metabolism of bile acids
    Dawson, Paul A.
    Karpen, Saul J.
    [J]. JOURNAL OF LIPID RESEARCH, 2015, 56 (06) : 1085 - 1099
  • [8] de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2015.186, 10.1038/nrgastro.2016.186]
  • [9] Bile acid nuclear receptor FXR and digestive system diseases
    Ding, Lili
    Yang, Li
    Wang, Zhengtao
    Huang, Wendong
    [J]. ACTA PHARMACEUTICA SINICA B, 2015, 5 (02) : 135 - 144
  • [10] Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review
    Fousekis, Fotios S.
    Theopistos, Vasileios I.
    Katsanos, Konstantinos H.
    Tsianos, Epameinondas V.
    Christodoulou, Dimitrios K.
    [J]. GASTROENTEROLOGY RESEARCH, 2018, 11 (02) : 83 - 94